NNW Headlines
Save 20% on Press Releases and More with NNW Prime! Click to View Details
Home » Events » Page 7

Category: Events

ThursdaySep 10, 2020 10:20 am

Thunderbird (AMS: TBIRD) Featured in Virtual Coverage of The Wall Street Investor Forum

Through Atomic Cartoons (Kids & Family) and Great Pacific Media (Factual & Scripted), Thunderbird (AMS: TBIRD) is a leader in developing and producing family entertainment and sold to key buyers including Netflix, HBO Max, Nickelodeon, Discovery Channel, Apple TV+, Disney+, NBCUniversal, CBC and traditional broadcast and cable channels in >250 territories globally. Their programs air daily in 40 different languages and include hits such as Beat Bugs, Kim's Convenience, Highway Thru Hell, Blade Runner 2049, Hello Ninja and the Peabody Award winning, Molly of Denali. Thunderbird is a rapidly growing and highly profitable, multi-platform business with FY2019 revenue of $61.5M…

Continue Reading

ThursdaySep 10, 2020 10:00 am

LexaGene Holdings Inc. (OTCQB: LXXGF) Featured in Virtual Coverage of The Wall Street Investor Forum

LexaGene Holdings Inc. (OTCQB: LXXGF) is a biotechnology company that develops genetic analyzers for pathogen detection and other molecular markers for on-site rapid testing in veterinary diagnostics and food safety, as well as for use in open-access markets such as clinical research, agricultural testing and biodefense. End-users collect a sample, load it onto the instrument with a sample preparation cartridge, enter sample ID and press 'go'. The LX Analyzer delivers excellent sensitivity, specificity and breadth of detection and can return results in about one hour. The unique open-access feature is designed for custom testing so that end-users can load their…

Continue Reading

ThursdaySep 10, 2020 9:40 am

Exro Technologies Inc. (OTCQB: EXROF) Featured in Virtual Coverage of The Wall Street Investor Forum

Exro Technologies Inc. (OTCQB: EXROF) is a clean tech company that has developed a new class of control technology for electric powertrains. Exro's advanced motor control technology, 'Coil Driver', expands the capabilities of electric motors and powertrains. The limitations of traditional electric machines and power technology have become more apparent. In many increasingly prominent applications, traditional methods cannot meet the required performance. Exro offers a new solution for system optimization through implementation of the technology, which can yield the following results: increased drive cycle efficiency, reduced system volume, reduced weight and expanded torque and speed capabilities. For more information, visit…

Continue Reading

ThursdaySep 10, 2020 9:20 am

Helius Medical Technologies (NASDAQ: HSDT) Featured in Virtual Coverage of The Wall Street Investor Forum

Helius Medical Technologies (NASDAQ: HSDT) is a neurotech company focused on neurological wellness. The company's purpose is to develop, license and acquire unique and non-invasive platform technologies that amplify the brain's ability to heal itself. The company's first product in development is the Portable Neuromodulation Stimulator (PoNS™). Helius was formed as a joint venture between scientists and commercialization experts to address the enormous implications of a massive unmet medical need in the market. For more information, visit the company's website at www.heliusmedical.com To register for The Wall Street Investor Forum and watch the live presentation, visit http://ibn.fm/TWSIFRegistration To view IBN’s…

Continue Reading

ThursdaySep 10, 2020 9:00 am

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Featured in Virtual Coverage of The Wall Street Investor Forum

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) develops novel treatments for primary and metastatic cancers of the brain and central nervous system. The company's lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (GBM), an aggressive and incurable form of brain cancer. CNS holds a worldwide exclusive license to the Berubicin chemical compound and has acquired all data and know-how from Reata Pharmaceuticals, Inc. related to a completed Phase 1 trial with Berubicin in GBM, which Reata conducted in 2006. By the end of 2020, CNS expects to commence a Phase 2 clinical trial of Berubicin for the treatment…

Continue Reading

WednesdaySep 09, 2020 2:45 pm

LexaGene Holdings Inc. (TSX.V: LXG) (OTCQB: LXXGF) Featured in Virtual Coverage of The Wall Street Investor Forum

LexaGene Holdings Inc. (TSX.V: LXG) (OTCQB: LXXGF) is a biotechnology company that develops genetic analyzers for pathogen detection and other molecular markers for on-site rapid testing in veterinary diagnostics and food safety, as well as for use in open-access markets such as clinical research, agricultural testing and biodefense. End-users collect a sample, load it onto the instrument with a sample preparation cartridge, enter sample ID and press 'go'. The LX Analyzer delivers excellent sensitivity, specificity and breadth of detection and can return results in about one hour. The unique open-access feature is designed for custom testing so that end-users can…

Continue Reading

WednesdaySep 09, 2020 10:14 am

Aptorum Group Ltd. (NASDAQ: APM) (Euronext Paris: APM) Featured in Virtual Coverage of The Wall Street Investor Forum

Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a biopharmaceutical company focused on novel therapeutics including the development of next-generation approach therapeutics targeting antimicrobial resistance, today announced President and Executive Director, Darren Lui, will present at the Wall Street Investor Forum on Thursday, September 10, 2020, at 1:00 PM ET. To listen to Aptorum Group’s presentation, please register at https://www.webcaster4.com/Webcast/Page/2487/36881 To register for The Wall Street Investor Forum and watch other live presentations, visit http://ibn.fm/TWSIFRegistration To view IBN’s virtual coverage of The Wall Street Investor Forum, visit https://ibn.fm/TWSIF About Aptorum Group Aptorum Group Limited (Nasdaq: APM, Euronext…

Continue Reading

TuesdaySep 08, 2020 2:45 pm

RedHill Biopharma Ltd. (NASDAQ: RDHL) Featured in Virtual Coverage of The Wall Street Investor Forum

RedHill Biopharma Ltd. (Nasdaq: RDHL) is a specialty biopharmaceutical company primarily focused on gastrointestinal diseases. RedHill promotes the gastrointestinal drugs, Movantik® for opioid-induced constipation in adults, Talicia® for the treatment of Helicobacter pylori (H. pylori) infection in adults, and Aemcolo® for the treatment of travelers’ diarrhea in adults. RedHill’s key clinical late-stage development programs include: (i) RHB-204, with a planned pivotal Phase 3 study for pulmonary nontuberculous mycobacteria (NTM) infections; (ii) opaganib (Yeliva®), a first-in-class SK2 selective inhibitor targeting multiple indications with a Phase 2/3 program for COVID-19 and ongoing Phase 2 studies for prostate cancer and cholangiocarcinoma; (iii) RHB-104,…

Continue Reading

TuesdaySep 01, 2020 12:41 pm

RedHill Biopharma Ltd. (NASDAQ: RDHL) Featured in Virtual Coverage of The Wall Street Investor Forum

RedHill Biopharma Ltd. (Nasdaq: RDHL) is a specialty biopharmaceutical company primarily focused on gastrointestinal diseases. RedHill promotes the gastrointestinal drugs, Movantik® for opioid-induced constipation in adults, Talicia® for the treatment of Helicobacter pylori (H. pylori) infection in adults, and Aemcolo® for the treatment of travelers’ diarrhea in adults. RedHill’s key clinical late-stage development programs include: (i) RHB-204, with a planned pivotal Phase 3 study for pulmonary nontuberculous mycobacteria (NTM) infections; (ii) opaganib (Yeliva®), a first-in-class SK2 selective inhibitor targeting multiple indications with a Phase 2/3 program for COVID-19 and ongoing Phase 2 studies for prostate cancer and cholangiocarcinoma; (iii) RHB-104,…

Continue Reading

MondayAug 31, 2020 12:53 pm

FinovateFall Digital to Showcase Latest Financial Technologies

Demos of cutting-edge technologies from over 30 start-ups Over 120 domain experts slated to address participants Some 1,600 key influencers expected to attend Q&As with presenters Network at one-to one meetings, small-group chats When FinovateFall Digital gets underway Sept. 14–18, 2020, the online virtual event will be shining the spotlight on a host of new technologies that are changing the financial services landscape in unimaginable ways. Technologies on display include some that aggregate data to discern patterns and trends, others designed to combat fraud, one that holds the promise of reducing origination costs for lenders, and a few that are…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000

NetworkNewsWire

1108 Lavaca St
Suite 110-NNW
Austin, TX 78701
(512) 354-7000

Copyright . NetworkNewsWire® / 1108 Lavaca St Suite 110-NNW Austin, TX 78701 (512) 354-7000 / Disclaimers